V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20207633 | 20134838 | 1.58 | 47 | Palliative (P) | 2018-01-26 | 2018-01-26 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101468877 |
| 20207672 | 20134839 | 0 | 63.9 | Neo-adjuvant (N) | 2017-04-03 | 2017-04-16 | Capecitabine + Streptozocin | N | N | GEMCITABINE + PACLITAXEL | 101483646 |
| 20207716 | 20134840 | 1.58 | 105.5 | Palliative (P) | 2017-06-08 | 2017-06-19 | Capecitabine + Streptozocin | 02 | N | CETUXIMAB + IRINOTECAN | 101534386 |
| 20207941 | 20134841 | 1.6 | 93.1 | Palliative (P) | 2019-10-13 | 2019-10-20 | COSMIC TRIAL | 02 | N | FLUOROURACIL + RT | 100556932 |
| 20208048 | 20134842 | 0 | 0 | 03 | 2017-07-24 | 2017-09-12 | CARBOPLATIN + RT | Y | N | AML17 TRIAL | 101311813 |
| 20208052 | 20134843 | 1.87 | 69.9 | Curative (C) | 2019-04-17 | 2019-04-23 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100104189 |
| 20208087 | 20134844 | 1.47 | 91.9 | Palliative (P) | 2017-10-01 | 2017-10-19 | null | 02 | N | FCARBOST | 101381010 |
| 20208300 | 20134845 | 1.83 | 67.05 | Neo-adjuvant (N) | 2016-08-23 | 2017-06-03 | Carbo F | 02 | N | EOF | 100224302 |
| 20208403 | 20134846 | 1.49 | 93 | 03 | 2020-07-25 | 2020-07-29 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | null | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 101228832 |
| 20208417 | 20134847 | 1.65 | 69.8 | null | 2019-10-22 | 2019-10-23 | VDC | 01 | null | PHITT D SIOPEL-4 (A1, A2, A3) | 100486419 |
| 20208428 | 20134848 | 1.85 | 100 | Adjuvant (A) | 2018-01-26 | 2018-02-15 | Bendamustine+Rituximab(Sub Courses) | 02 | null | SCOPE2 TRIAL | 101514390 |
| 20208450 | 20134849 | 1.71 | 78.3 | Adjuvant (A) | 2020-05-02 | 2020-05-02 | OSIMERTINIB | 02 | N | TEMOZOLOMIDE | 101828578 |
| 20208539 | 20134850 | 1.81 | 73.3 | null | 2016-07-16 | 2016-11-22 | PACLITAXEL + RAMUCIRUMAB | 02 | null | TOPOTECAN | 101205013 |
| 20208547 | 20134851 | 1.69 | 46.8 | Disease modification (D) | 2017-10-10 | 2017-10-15 | CAPECITABINE + CETUXIMAB | N | Y | CAPECITABINE + CETUXIMAB + OXALIPLATIN | 101842607 |
| 20208568 | 20134852 | 1.82 | 67.95 | null | 2018-10-02 | 2019-01-31 | FLUOROURACIL + Irinotecan Liposomal | 02 | N | CAPE + OXALIPLATIN + TRASTUZUMAB | 100615101 |
| 20208624 | 20134853 | 1.3 | 68.7 | Palliative (P) | 2020-09-30 | 2020-10-03 | Bortezomib (weekly) | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100157115 |
| 20208758 | 20134854 | 1.61 | 116 | Curative (C) | 2016-11-29 | 2017-01-04 | POMALIDOMIDE | N | Y | COSMIC TRIAL | 100476395 |
| 20208807 | 20134855 | 1.79 | 15.9 | 03 | 2019-01-14 | 2019-01-14 | Cabazitaxel | N | null | DABRAFENIB | 100615052 |
| 20208899 | 20134858 | 1.61 | 72.7 | Palliative (P) | 2018-08-31 | 2018-08-31 | Cisplatin +FU +Trastuzumab - Load | 02 | null | STS RHABDO VIT0910 VINC IRINO TEMOZ | 100121350 |
| 20208924 | 20134859 | null | 53.8 | Disease modification (D) | 2018-11-21 | 2018-11-28 | Atezolizumab | 02 | N | CISPLATIN + PEMETREXED | 101629550 |
| 20208932 | 20134860 | 1.57 | 103 | null | 2018-10-23 | 2018-10-24 | CAPECITABINE + IRINOTECAN + Panitumumab | 01 | null | HEPATOBLASTOMA VHR BLOCK C CARBO (AUC6.6)/DOX | 101555902 |
| 20208995 | 20134861 | 1.65 | 53.8 | Palliative (P) | 2017-02-09 | 2017-02-23 | ECarboX | 02 | N | INTERAACT TRIAL | 101485433 |
| 20209216 | 20134863 | 1.82 | 83.2 | null | 2014-01-17 | 2016-12-09 | null | null | null | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100051258 |
| 20209271 | 20134864 | null | null | Palliative (P) | 2017-06-24 | 2017-06-25 | MITOMYCIN | 02 | N | DERAZANTINIB | 101477469 |
| 20209418 | 20134865 | 1.65 | 90.5 | Neo-adjuvant (N) | 2018-03-09 | 2018-03-22 | CARBOPLATIN + GEMCITABINE | 02 | Y | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 101261389 |
| 20209456 | 20134866 | 1.77 | 53.2 | Curative (C) | 2017-08-23 | 2017-08-23 | CAM-PLEX Trial | 01 | N | GEMCARBO | 101338801 |
| 20209458 | 20134867 | 1.8 | 65 | Palliative (P) | 2020-01-12 | 2020-01-13 | Capecitabine + Streptozocin | N | null | CTD | 101664351 |
| 20209528 | 20134868 | 1.55 | 42 | Palliative (P) | 2019-12-12 | 2019-12-28 | Fluorouracil + Streptozocin | 02 | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101680228 |
| 20209813 | 20134869 | null | 81.6 | Neo-adjuvant (N) | 2016-02-15 | 2016-03-22 | DARATUMUMAB | 01 | null | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 101671570 |
| 20209863 | 20134870 | 1.84 | null | Palliative (P) | 2019-01-02 | 2019-01-31 | BEAM | 02 | N | PAZOPANIB | 101409712 |
| 20209999 | 20134871 | 1.9 | 0 | 03 | null | 2016-05-18 | DABRAFENIB | null | N | DABRAFENIB + TRAMETINIB | 101760990 |
| 20210102 | 20134873 | 1.65 | 72.3 | null | 2020-09-24 | 2021-04-28 | CAPECITABINE + OXALIPLATIN + PEMBROLIZUMAB | 01 | N | CARBOPLATIN + VINORELBINE | 101689861 |
| 20210425 | 20134876 | 1.69 | 75 | Curative (C) | 2019-08-30 | 2019-09-20 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | CETUXIMAB + IRINOTECAN | 101715000 |
| 20210432 | 20134877 | 1.8 | 70.6 | Adjuvant (A) | 2020-07-16 | 2020-07-16 | Carboplatin + Pemetrexed | N | N | CYTARABINE | 100377845 |
| 20210435 | 20134878 | 1.86 | 115.6 | Curative (C) | 2017-12-05 | 2019-06-29 | Atezolizumab + Bevacizumab + Carboplatin + Paclitaxel | N | N | PHITT D SIOPEL-4 (A1, A2, A3) | 100028847 |
| 20210468 | 20134879 | 1.52 | 65.8 | Curative (C) | 2020-01-27 | 2021-06-12 | IBRUTINIB | 02 | null | FLUOROURACIL + OXALIPLATIN + TRASTUZUMAB | 100367677 |
| 20210598 | 20134880 | 1.65 | 133.2 | null | 2020-10-31 | 2020-11-04 | Liposomal Doxorubicin (Caelyx) | N | null | FLUOROURACIL + PANITUMUMAB | 100603779 |
| 20210629 | 20134881 | 1.58 | null | null | 2020-06-24 | 2020-08-06 | CAPE + OXALIPLATIN + TRASTUZUMAB | null | N | BUSULFAN | 101794725 |
| 20210841 | 20134882 | 1.64 | 87 | Palliative (P) | 2018-02-02 | 2018-04-27 | DABRAFENIB + TRAMETINIB | 02 | N | CISPLATIN + EPIRUBICIN + RALTITREXED | 100112008 |
| 20210844 | 20134883 | 1.77 | 66 | Palliative (P) | 2020-03-08 | 2020-03-29 | GEFITINIB | 02 | N | ESPAC TRIAL | 100494692 |
| 20210893 | 20134884 | 1.78 | 46.8 | null | null | 2018-09-15 | PHITT D2 Carboplatin / etoposide | 01 | N | GEMCITABINE + PACLITAXEL | 101295603 |
| 20210918 | 20134885 | 1.65 | 68.2 | Palliative (P) | 2016-08-05 | 2016-08-05 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | FULVESTRANT + PALBOCICLIB | 100555649 |
| 20210930 | 20134886 | 1.52 | null | null | 2019-08-03 | 2019-08-03 | PHITT D Carboplatin/Doxorubicin | 02 | null | RITUXIMAB | 101413441 |
| 20210988 | 20134887 | 1.75 | 88 | Neo-adjuvant (N) | 2018-03-09 | 2018-03-22 | CISPLATIN + FLUOROURACIL + RT | null | N | BORTEZOMIB | 101618503 |
| 20210999 | 20134888 | 1.83 | 78.6 | Neo-adjuvant (N) | 2019-04-04 | 2019-04-06 | FOCUS4 TRIAL | 01 | Y | CETUXIMAB + OXALIPLATIN + RALTITREXED | 100573211 |
| 20211066 | 20134889 | null | null | Palliative (P) | 2016-09-19 | 2019-04-30 | CAP + RT | 02 | null | BACILLUS CALMETTE-GUERIN | 100559799 |
| 20211131 | 20134890 | 1.77 | 0 | null | null | 2020-07-04 | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | N | null | ECARBOX | 100965481 |
| 20211169 | 20134892 | 1.56 | 80 | 03 | 2017-11-11 | 2017-12-05 | AML 18 TRIAL | 02 | N | GEMCARBO | 101578880 |
| 20211198 | 20134893 | 1.84 | 83.6 | Palliative (P) | 2019-01-25 | 2019-03-31 | GO2 TRIAL | 02 | Y | ETOPOSIDE + IFOSFAMIDE | 100199856 |
| 20211333 | 20134894 | 1.65 | 87 | null | 2018-03-18 | 2018-09-03 | TOPOTECAN | 01 | null | BACILLUS CALMETTE-GUERIN | 101221870 |